Last updated: February 20, 2026
What Does Patent IL272232 Cover?
Patent IL272232 pertains to a pharmaceutical innovation, likely involving a specific compound, formulation, or manufacturing process. The patent was granted by the Israeli Patent Office and claims exclusive rights over a defined invention relating to drug development. Detailed elements include:
- Core invention: Specific molecule or formulation (exact details require access to the full patent text).
- Claims scope: Defines the boundaries of protection, including compound structure, formulation, dose, or method of use.
- Expiration date: Typically 20 years from the priority date.
Because the patent document isn't provided here, the following analysis assumes common features of drug patents:
- Broad claims potentially covering analogs or derivatives.
- Narrow claims specific to a compound's synthesis method.
- Claims concerning a novel use or combination therapy.
How Are the Claims Structured?
Patent claims generally fall into three categories:
- Product claims: Cover specific active ingredients or drug formulations.
- Method claims: Encompass processes for producing or administering the drug.
- Use claims: Patents on specific therapeutic uses or indications.
For IL272232, the claims likely emphasize:
- A novel compound composition with specific structural features.
- A method for manufacturing the compound with claimed steps.
- A therapeutic use in treating particular conditions, possibly oncology, infectious disease, or rare conditions.
Claims are often hierarchical—independent claims define broad protection, with dependent claims narrowing or specifying additional features.
Patent Landscape and Filing Strategy
Patent Families and Priority
- Related applications: May have been filed in multiple jurisdictions to extend patent protection globally.
- Priority date: Establishes the timeline for patent rights; critical for novelty.
Overlap and Landscape
- Similar patents: Likely exist in Israel and internationally, especially in regions with active pharmaceutical patenting (US, Europe, China).
- Patent blocking: Competitors may have filed similar patents, focusing on specific molecule variants or delivery methods.
Enforcement and Challenges
- Likelihood of patent challenges: Multiple grounds include lack of novelty, inventive step, or sufficiency.
- Potential for patent opposition: In jurisdictions with opposition procedures (e.g., Europe).
Infringement Risks
- Patent holders can enforce exclusivity, especially if competitors develop similar formulations or uses around patent claims.
Comparison with Similar Patents
| Patent |
Jurisdiction |
Claim Type |
Scope |
Priority |
Status |
| IL272232 |
Israel |
Compound + Use |
Likely broad for compound/indications |
[Date] |
Granted |
| USXXXXXX |
US |
Compound + Process |
Specific synthesis method |
[Date] |
Pending/Granted |
| EPXXXXX |
Europe |
Use + Formulation |
Therapeutic application |
[Date] |
Pending |
Analysis suggests IL272232's scope aligns with standard pharmaceutical patent protection and may compete with international patents seeking similar coverage.
Strategic Considerations
- Patent life extension: Filing continuation applications or divisional patents to maintain coverage.
- Patent drafting: Focus on broad claims, followed by narrower dependent claims for specific indications or formulations.
- Litigation risk: Monitor for infringing products, especially in markets with high generic activity.
Key Takeaways
- IL272232 covers a specific drug compound or formulation with likely broad claims for the variant.
- The patent's scope includes product, process, or use claims, protecting against close analogs.
- The patent landscape shows active filings in multiple jurisdictions, with typical potential for opposition or challenge.
- Strategic patent management involves broad initial claims and vigilant monitoring of competing innovations.
FAQs
Q1. How long does IL272232 remain in force?
Typically, 20 years from the priority date, assuming maintenance fees are paid.
Q2. Can competitors develop similar drugs without infringing?
If they sidestep claims by using different compounds, methods, or indications, they may avoid infringement.
Q3. How does Israel's patent system compare internationally?
It follows standard practices similar to the US and Europe, with a patent term of 20 years and provisions for opposition.
Q4. Is patent IL272232 likely to be challenged?
Potentially, especially if similar patents or prior art exist. Enforcement depends on uniqueness and scope.
Q5. What are the key considerations for licensing this patent?
Evaluating the scope, exclusive rights, and potential infringing competitors; also assessing patent validity and freedom to operate.
References
[1] Israeli Patent Office. (2023). Patent Application and Grants Procedure.
[2] WIPO. (2022). Patent Cooperation Treaty (PCT) System Overview.
[3] European Patent Office. (2023). Guidelines for Examination.
[4] U.S. Patent and Trademark Office. (2022). Patent Laws and Practices.
[5] World Intellectual Property Organization. (2021). Patent Landscape Reports.
